Kiat Ruxrungtham

Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection

Netanya G. Sandler, Handan Wand, Annelys Roque et al. · The Journal of Infectious Diseases · 2011 · 1.1K citations · Full text

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

Frank van Leth, Praphan Phanuphak, Kiat Ruxrungtham et al. · The Lancet · 2004 · 683 citations

Treatment And Prevention, Medicine, First-line Antiretroviral Therapy +9

Comprehensive serological profiling of human populations using a synthetic human virome

George Xu, Tomasz Kula, Qikai Xu et al. · Science · 2015 · 487 citations · Full text

Genetic Testing, Molecular Epidemiology, Viral Diagnostics +22

Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial

Calvin Cohen, Jaime Andrade‐Villanueva, Bonaventura Clotet et al. · The Lancet · 2011 · 369 citations

Treatment And Prevention, Medicine, Human Retrovirus +9

Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial

José Valdez Madruga, Daniel Berger, Marilyn McMurchie et al. · The Lancet · 2007 · 330 citations

Treatment And Prevention, Antiviral Drug Development, Antiviral Therapy +5